- Filed
- May 7, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Mar 31, 2024 | 59.67M sh |
| Shares Outstanding | Q1 2024 · Dec 31, 2023 | 58.93M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $8.3M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $11.6M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$26.13M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$20.09M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $52.2M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $53.03M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $176.37M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $151.2M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $21M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $30.59M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $150.46M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $131.33M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 54.49M sh |
| Capex restated | Q1 2024 · Mar 31, 2023 | $307K |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2023 | −$696K |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.11 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.11 |
| Net Income restated | Q1 2024 · Mar 31, 2023 | −$6.07M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$5.53M |
| Revenue restated | Q1 2024 · Mar 31, 2023 | $32.15M |